Immune-Metabolic Interactions and T Cell Tolerance in Pregnancy.
Files
(Accepted version)
Date
2022
Authors
Moldenhauer, L.M.
Hull, M.L.
Foyle, K.L.
McCormack, C.D.
Robertson, S.A.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Journal of Immunology, 2022; 209(8):1426-1436
Statement of Responsibility
Lachlan M. Moldenhauer, M. Louise Hull, Kerrie L. Foyle, Catherine D. McCormack, and Sarah A. Robertson
Conference Name
Abstract
Pregnancy depends on a state of maternal immune tolerance mediated by CD4+ regulatory T (Treg) cells. Uterine Treg cells release anti-inflammatory factors, inhibit effector immunity, and support adaptation of the uterine vasculature to facilitate placental development. Insufficient Treg cells or inadequate functional competence is implicated in infertility and recurrent miscarriage, as well as pregnancy complications preeclampsia, fetal growth restriction, and preterm birth, which stem from placental insufficiency. In this review we address an emerging area of interest in pregnancy immunology-the significance of metabolic status in regulating the Treg cell expansion required for maternal-fetal tolerance. We describe how hyperglycemia and insulin resistance affect T cell responses to suppress generation of Treg cells, summarize data that implicate a role for altered glucose metabolism in impaired maternal-fetal tolerance, and explore the prospect of targeting dysregulated metabolism to rebalance the adaptive immune response in women experiencing reproductive disorders.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
© 2022 by The American Association of Immunologists, Inc